HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gender Stereotypes in Ads Face Falling Foul Of New UK Regulations

Executive Summary

Consumer health firms advertising in the UK - whether on television, online or through social media - will from June face tighter regulation aimed at protecting consumers from harmful gender stereotypes.

You may also be interested in...



Implied Health Claims Ruling Indicates Tougher Stance By UK Ad Regulator

UK ad regulator ASA's ruling against Red Bull indicates a hardening approach to interpreting implied health claims. Food supplement ads that imply a "general impression of healthy living" could be caught out, warns Jessica Burt of law firm Mills & Reeve.

ASA Reinforces That Exceptions To Influencer #Ad Requirements Are Hard To Come By

The Advertising Standards Authority rejects brand ambassador Olivia Buckland’s argument that a May Instagram post touting W7 eyeshadows did not require a disclosure because she wasn’t acting on a specific request or contractual obligation with the company.

UK Proposes Accelerating Authorizations Of Novel Supplements Like CBD

UK Food Standards Agency proposes shaving a minimum of three months off novel food authorization procedure as part of wider plans to shake-up the process for products like CBD supplements.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel